510(k) K884591
K884591 is an FDA 510(k) premarket notification submitted by Hillcrest Biologicals for the device "EBV-VCA ANTIBODY (IGG)". The FDA issued a decision of Substantially Equivalent on Jan 24, 1989. The device falls under product code GNP (Antiserum, Cf, Epstein-Barr Virus), a Class I device regulated under 21 CFR 866.3235. Hillcrest Biologicals has 32 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 24, 1989
- Date Received
- Nov 3, 1988
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antiserum, Cf, Epstein-Barr Virus
- Device Class
- Class I
- Regulation Number
- 866.3235
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Hillcrest Biologicals? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.